GLENMEDE TRUST CO NA

Bank

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 314949 PHILADELPHIA, PA

Position in CRNX

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$1,194,932

+$132,754 QoQ

Shares Held

31,933

+9.2% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#116

of 264 holders

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GLENMEDE TRUST CO NA holds $148,775,467 across 46 Biotechnology names. CRNX ranks #15 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	538,822	$61,080,861
2	ACAD	Acadia Pharmaceuticals Inc	488,546	$12,360,212
3	BMRN	Biomarin Pharmaceutical Inc	206,405	$11,810,493
4	HALO	Halozyme Therapeutics, Inc.	141,317	$11,060,881
5	REGN	Regeneron Pharmaceuticals, Inc.	17,621	$10,987,396
6	VRTX	Vertex Pharmaceuticals Inc / Ma	12,722	$6,319,398
7	VCEL	Vericel Corp	139,921	$6,225,084
8	LGND	Ligand Pharmaceuticals Inc	7,637	$2,413,979

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,194,932	31,933	+9.2%	Shares	Sole	2026-08-10
2026-03-31	$1,062,178	29,245	+72.6%	Shares	Sole	2026-05-26
2025-12-31	$788,743	16,944	-2.4%	Shares	Sole	2026-02-17
2025-03-31	$581,986	17,352	-0.2%	Shares	Sole	2025-05-15
2024-12-31	$889,150	17,390	+1.4%	Shares	Sole	2025-02-14
2024-09-30	$876,058	17,144	-4.5%	Shares	Sole	2024-11-13
2024-06-30	$804,025	17,951	+158.7%	Shares	Sole	2024-08-14
2024-03-31	$324,767	6,938	-7.7%	Shares	Sole	2024-05-15
2023-09-30	$223,585	7,518	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.